In-Stent RestenosisKIM, Michael S; DEAN, Larry S.Cardiovascular therapeutics (Print). 2011, Vol 29, Num 3, pp 190-198, issn 1755-5914, 9 p.Article

Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut appositionTANIGAWA, Jun; BARLIS, Peter; DI MARIO, Carlo et al.EuroIntervention. 2007, Vol 3, Num 1, pp 128-136, issn 1774-024X, 9 p.Article

Drug eluting stents in 2005GERSHLICK, A. H.Heart. Supplement. 2005, Vol 91, Num 3, pp iii24-iii31Article

Update on drug-eluting stents : as good as it gets?JAIN, Ajay K; MATHUR, Anthony.Clinical medicine. 2007, Vol 7, Num 4, pp 401-404, issn 1470-2118, 4 p.Article

XTENT® Custom NX™ drug eluting stent systemsEVANS, Laura Wilkes; DORAN, Paula; MARCO, Philippe et al.EuroIntervention. 2007, Vol 3, Num 1, pp 158-161, issn 1774-024X, 4 p.Article

Current Status of Drug Eluting StentsKIPSHIDZE, Nicholas.Current pharmaceutical design (Print). 2010, Vol 16, Num 36, issn 1381-6128, 96 p.Serial Issue

Current Status of Drug-Eluting StentsRABER, Lorenz; WINDECKER, Stephan.Cardiovascular therapeutics (Print). 2011, Vol 29, Num 3, pp 176-189, issn 1755-5914, 14 p.Article

Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting StentsMAURI, Laura; KEREIAKES, Dean J; HOLMES, David R et al.The New England journal of medicine. 2014, Vol 371, Num 23, pp 2155-2166, issn 0028-4793, 12 p.Article

AXXESS™ Biolimus A9® eluting bifurcation stent systemVERHEYE, Stefan; TRAUTHEN, Brett.EuroIntervention. 2007, Vol 2, Num 4, pp 506-508, issn 1774-024X, 3 p.Article

Les stents coronaires à élution sont-ils dangereux? : Cardiologie = Are drug-eluting stents dangerous ?DE BENEDETTI, Edoardo; URBAN, Philip.Revue médicale suisse. 2007, Vol 3, Num 102, pp 656-658, issn 1660-9379, 3 p.Article

Health economics : drug-eluting stents -are they worth the money?GERSHLICK, Anthony H; FEARN, Steve.EuroIntervention. 2008, Vol 4, issn 1774-024X, C75-C79, SUPCArticle

Optical coherence tomography analysis for restenosis of drug-eluting stentsYAMAMOTO, Masanori; TAKANO, Masamichi; MURAKAMI, Daisuke et al.International journal of cardiology. 2011, Vol 146, Num 1, pp 100-103, issn 0167-5273, 4 p.Article

Setting acceptance criteria for validation of analytical methods of drug eluting stents: Minimum requirements for analytical variabilityKAMBERI, Marika; GARCIA, Hector; FEDER, Debra P et al.European journal of pharmaceutical sciences. 2011, Vol 42, Num 3, pp 230-237, issn 0928-0987, 8 p.Article

A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecanSEGEV, Amit; NILI, Nafiseh; OSHEROV, Azriel B et al.EuroIntervention. 2010, Vol 6, Num 1, pp 134-140, issn 1774-024X, 7 p.Article

Polymers for Drug Eluting StentsPARKER, Ted; DAVE, Vipul; FALOTICO, Robert et al.Current pharmaceutical design (Print). 2010, Vol 16, Num 36, pp 3978-3988, issn 1381-6128, 11 p.Article

Predictors of angiographic restenosis after drug eluting stents in the coronary arteries: contemporary practice in real world patientsRATHORE, Sudhir; TERASHIMA, Mitsuyasu; ASAKURA, Keiko et al.EuroIntervention. 2009, Vol 5, Num 3, pp 349-354, issn 1774-024X, 6 p.Article

Sculptured drug-eluting stent for the on-site delivery of tacrolimusMINGHETTI, Paola; CILURZO, Francesco; SELMIN, Francesca et al.European journal of pharmaceutics and biopharmaceutics. 2009, Vol 73, Num 3, pp 331-336, issn 0939-6411, 6 p.Article

Evaluation of neointimal coverage and apposition with various drug-eluting stents over 12 months after implantation by optical coherence tomographySHAN LI; YUTANG WANG; LUYUE GAI et al.International journal of cardiology. 2013, Vol 162, Num 3, pp 166-171, issn 0167-5273, 6 p.Article

Drug eluting stents: Developments and current statusKHAN, Wahid; FARAH, Shady; DOMB, Abraham J et al.Journal of controlled release. 2012, Vol 161, Num 2, pp 703-712, issn 0168-3659, 10 p.Article

The optimal timing for non-cardiac surgery after percutaneous coronary intervention with drug-eluting stentsCHEOL UNG CHOI; RHA, Seung-Woon; CHANG GYU PARK et al.International journal of cardiology. 2010, Vol 139, Num 3, pp 313-316, issn 0167-5273, 4 p.Article

Long-term clinical outcome of alternative treatment strategies for drug-eluting stents restenosisLIISTRO, Francesco; FINESCHI, Massimo; GROTTI, Simone et al.EuroIntervention. 2009, Vol 5, Num 4, pp 454-459, issn 1774-024X, 6 p.Article

Understanding the different pattern of in-stent restenosis between sirolimus-and paclitaxel-eluting stents; still long way to goPARK, Chang-Bum; HONG, Myeong-Ki; CHEOL WHAN LEE et al.International journal of cardiology. 2008, Vol 130, Num 1, pp 80-81, issn 0167-5273, 2 p.Article

Dual antiplatelet therapy in the drug-eluting stent eraWALLENTIN, Lars.European heart journal supplements. 2008, Vol 10, Num D, issn 1520-765X, D38-D44Article

Intravascular ultrasound findings in patients with restenosis of sirolimus-and paclitaxel-eluting stentsOHLMANN, Patrick; MINTZ, Gary S; KIM, Sang-Wook et al.International journal of cardiology. 2008, Vol 125, Num 1, pp 11-15, issn 0167-5273, 5 p.Article

Safety of direct stenting with the Endeavor stent: results of the Endeavor II continued access registrySCHULTHEISS, Hans-Peter; GRUBE, Eberhard; KUCK, Karl-Heinz et al.EuroIntervention. 2007, Vol 3, Num 1, pp 76-81, issn 1774-024X, 6 p.Article